Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Grand Pharmaceutical Group Limited ( (HK:0512) ) has shared an announcement.
Grand Pharmaceutical Group Limited announced its upcoming Annual General Meeting (AGM) to be held on April 10, 2025, in Hong Kong. Key agenda items include the adoption of financial statements, declaration of a final dividend, re-election of directors, and re-appointment of auditors. Additionally, the company seeks approval for directors to allot and issue shares, with limitations on the aggregate number of shares to be issued. These resolutions aim to strengthen the company’s governance and financial strategies, potentially impacting its market position and shareholder value.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited is a company incorporated in Bermuda, operating within the pharmaceutical industry. It is listed on the Stock Exchange of Hong Kong and focuses on the development, production, and distribution of pharmaceutical products.
YTD Price Performance: 27.29%
Average Trading Volume: 5,721,817
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$21.44B
For detailed information about 0512 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue